Similar Search Results

Towards more affordable medicine: A proposal to waive certain obligations from the Agreement on TRIPS

Dhar, Biswajit; Gopakumar, K. M. - 2020

Access to medicines at prices patients can afford has been a recurrent concern for the global community ever since the Agreement on Trade Related Aspects of Intellectual Property (TRIPS) was adopted in 1995 as one of the agreements under the World Trade Organization (WTO). In 2001, WTO Members...

Persistent link: https://www.econbiz.de/10012316008

Regulating drugs : resolving conflicts with the UN drug control treaty system

Walsh, John; Jelsma, Martin - In: Journal of illicit economies and development : JIED 1 (2019) 3, pp. 266-271

of psychoactive substances. Regulated cannabis and coca markets are already a reality in several countries, with more … treaties is untenable and risks undermining basic principles of international law. States enacting cannabis regulation must … drug control conventions so as to accommodate cannabis regulation is not feasible for the foreseeable future, and the …

Persistent link: https://www.econbiz.de/10012261153

Access to medicines after TRIPS : is compulsory licensing an effective mechanism to lower drug prices? ; a review of the existing evidence

Urias, Eduardo; Ramani, Shyama V. - In: Journal of International Business Policy : JIBP 3 (2020) 4, pp. 367-384

Persistent link: https://www.econbiz.de/10012405471

Big pharma and monopoly capitalism: a long-term view

Dosi, Giovanni; Marengo, Luigi; Staccioli, Jacopo; … - 2021

Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...

Persistent link: https://www.econbiz.de/10012604733

How does basic research improve innovation performance in the world's major pharmaceutical firms?

Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424

Persistent link: https://www.econbiz.de/10013170079

The tools of globalization : ways of regulating and the structure of the international regime for pharmaceuticals

Demortain, David - In: Review of international political economy : RIPE 22 (2015) 6, pp. 1249-1275

Persistent link: https://www.econbiz.de/10011453911

The "5 Horsemen of the Apothecary" : lessons to be learned by the top pharmaceutical performers for 2014-2009

Trombetta, Bill - In: Journal of medical marketing : device, diagnostic and … 15 (2015) 3/4, pp. 81-89

Persistent link: https://www.econbiz.de/10011881395

The role of cross-national knowledge on organizational ambidexterity : a case of the global pharmaceutical industry

Dunlap, Denise; Marion, Tucker; Friar, John - In: Management learning : the journal for managerial and … 45 (2014) 4, pp. 458-476

Persistent link: https://www.econbiz.de/10010415282

COVID-19 vaccines and the role of patents

Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491

Persistent link: https://www.econbiz.de/10012800211

Harmonization of intellectual property rights across the globe : impact on India's pharmaceutical exports

Bhandarkar, Supriya - 2020

Persistent link: https://www.econbiz.de/10012518985

1
2
3
4
5
6
7
8
9
10
Next
Last